TRPA1 and peripheral arterial disease: In hindlimb ischemia and peripheral neuropathy, as experimental models of PAD, spontaneous pain-associated behavior during reperfusion was decreased following TRPA1 genetic ablation and pharmacological inhibition (39, 41, 43).